Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245501 · ClinicalTrials.gov registry record · NA
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety
A NA study of Anxiety Disorders, sponsored by University of Denver.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04245501 is a NA study of Anxiety Disorders that has completed, run by University of Denver. The registered enrollment target is 50 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04245501, a NA study of Anxiety Disorders, has completed, sponsored by University of Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety is the most common mental health problem in children and adolescents. This two-phased study will test the effects of an experimental computerized intervention aimed at reducing threat-based thinking (i.e., interpretation bias) in anxious youth. Participants in both the R61 (N=46) and R33 (N=72) trials will be youth ages 10 to 17 with a primary anxiety disorder (Separation, Social, Generalized). In the R61 trial, youth will be randomly assigned to receive 16 sessions over 4 weeks of either a personalized cognitive bias modification program for interpretation bias (CBM-I) or a computerized control condition (ICC). If CBM-I reduces interpretation bias significantly more than the ICC, the R33 trial will commence. In the R33, youth will be randomly assigned to either CBM-I or an equal amount of time in a cognitive restructuring intervention, which also aims to reduce threat-based thinking in anxiety. Please note that only the R61 phase of the trial has been completed and currently this record summary only reflects the R61 phase.
Conditions Studied
Interventions
- OTHER Cognitive Bias Modification for Interpretations (CBM-I)
- OTHER Interpretation Control Condition (ICC)
Study Locations (1)
Colorado
- BRAVE Lab, Department of Psychology, University of Denver - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-06-20 |
| Est. Completion | 2023-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04245501
The ClinicalTrials.gov registry entry for NCT04245501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (96% lower). The listed sponsor is University of Denver, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Bias Modification for Interpretations (CBM-I) is the first listed.
NCT04245501 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04245501 about?
NCT04245501 is a clinical study titled "Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety". Anxiety is the most common mental health problem in children and adolescents. This two-phased study will test the effects of an experimental computerized intervention aimed at reducing threat-based thinking (i.e., interpretation bias) in anxious youth. Participants in both the R61 (N=46) and R33 (N=...
What is the current status of trial NCT04245501?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-06-20. Estimated completion is 2023-11-15.
What conditions does trial NCT04245501 study?
This clinical trial studies the following conditions: Anxiety Disorders.
What interventions are being tested in trial NCT04245501?
The interventions under investigation include: Cognitive Bias Modification for Interpretations (CBM-I) (OTHER), Interpretation Control Condition (ICC) (OTHER).
Who is sponsoring clinical trial NCT04245501?
This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04245501 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.